U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C36H42N2
Molecular Weight 502.7321
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 2

SHOW SMILES / InChI
Structure of HEXAFLUORENIUM

SMILES

C[N+](C)(CCCCCC[N+](C)(C)C1C2=C(C=CC=C2)C3=C1C=CC=C3)C4C5=C(C=CC=C5)C6=C4C=CC=C6

InChI

InChIKey=HDZAQYPYABGTCL-UHFFFAOYSA-N
InChI=1S/C36H42N2/c1-37(2,35-31-21-11-7-17-27(31)28-18-8-12-22-32(28)35)25-15-5-6-16-26-38(3,4)36-33-23-13-9-19-29(33)30-20-10-14-24-34(30)36/h7-14,17-24,35-36H,5-6,15-16,25-26H2,1-4H3/q+2

HIDE SMILES / InChI

Molecular Formula C36H42N2
Molecular Weight 502.7321
Charge 2
Count
Stereochemistry MIXED
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Hexafluorenium inhibits the enzyme cholinesterase in the plasms, but apparently not at the neuromuscular juntion. It also has some nondepolarizing activity (tubocurarine-like) at the postjunctional membrane. In man hexafluorenium potentiates the muscle relaxant effects of succinylcholine. As such, smaller doses of succinylcholine are required and fewer side effects like fasciculations, twitching and postoperative muscle pain are experienced.

Originator

Curator's Comment: reference retrieved from http://www.drugfuture.com/chemdata/hexafluorenium-bromide.html | https://www.ncbi.nlm.nih.gov/pubmed/5354795

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P06276
Gene ID: 590.0
Gene Symbol: BCHE
Target Organism: Homo sapiens (Human)
2.4 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
MYLAXEN

Approved Use

Used as an adjunct with succinylcholine (or suxamethonium chloride) to prolong muscle relaxation and to prevent succinylcholine-induced muscle fasciculations.
PubMed

PubMed

TitleDatePubMed
Pseudocholinesterase enzyme deficiency: a case series and review of the literature.
2009 Dec 4
Sertraline-induced pseudocholinesterase enzyme deficiency.
2010 Nov 16
Patents

Patents

Sample Use Guides

Substance Class Chemical
Created
by admin
on Fri Dec 15 15:28:25 GMT 2023
Edited
by admin
on Fri Dec 15 15:28:25 GMT 2023
Record UNII
55W5L6G81R
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
HEXAFLUORENIUM
VANDF  
Common Name English
HEXAFLURONIUM
WHO-DD  
Common Name English
HEXAFLUORENIUM [VANDF]
Common Name English
HEXAFLUORENIUM CATION
Common Name English
HEXAMETHYLENEBIS(FLUOREN-9-YLDIMETHYLAMMONIUM)
Systematic Name English
1,6-HEXANEDIAMINIUM, N,N'-DI-9H-FLUOREN-9-YL-N,N,N',N'-TETRAMETHYL-
Systematic Name English
Hexafluronium [WHO-DD]
Common Name English
HEXAFLUORENIUM ION
Common Name English
Classification Tree Code System Code
WHO-ATC M03AC05
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
NCI_THESAURUS C47792
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
WHO-VATC QM03AC05
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID00859333
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
PRIMARY
NCI_THESAURUS
C76138
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
PRIMARY
HSDB
3230
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
PRIMARY
EVMPD
SUB14099MIG
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
PRIMARY
FDA UNII
55W5L6G81R
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
PRIMARY
RXCUI
26826
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
PRIMARY RxNorm
SMS_ID
100000077921
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
PRIMARY
DRUG BANK
DB00941
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
PRIMARY
PUBCHEM
3601
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
PRIMARY
CAS
4844-10-4
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
PRIMARY
MESH
C005034
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
PRIMARY
DRUG CENTRAL
1365
Created by admin on Fri Dec 15 15:28:25 GMT 2023 , Edited by admin on Fri Dec 15 15:28:25 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY